Advanced surgical procedures for pelvic organ prolapse are now being carried out at Petropavlovsk-Kamchatsky City Hospital.
Advanced Pelvic Organ Prolapse Surgeries Now Available in Petropavlovsk-Kamchatsky
Starting June 2025, City Hospital No. 2 in Petropavlovsk-Kamchatsky will offer advanced high-tech pelvic organ prolapse (POP) surgeries. These surgical procedures, which were developed by the N.I. Pirogov National Medical Surgical Center, will be available at the hospital's gynecological department.
Previously, similar surgeries in Kamchatka were performed using outdated protocols. However, with the introduction of these new techniques, residents in the region no longer have to travel outside for specialized care.
The gynecological department of Hospital No. 2 now offers not only specialized but also high-tech medical care for POP treatment in the city and the entire region of Petropavlovsk-Kamchatsky.
The high-tech POP surgeries utilize state-of-the-art robotic and laparoscopic techniques, including both mesh and non-mesh options. The surgeries aim to restore pelvic organ support by reinforcing pelvic floor structures.
One of the methods used involves implanting a mesh device called "Urosling-1" in the pelvic area. Over time, the implant integrates with the body, forming a supportive ligament for internal organs. Comparatively, robotic surgeries reduce operative times, blood loss, and surgical complications, and typically lead to faster recovery and less postoperative pain.
The effectiveness of these surgeries is supported by evidence showing better anatomical correction and symptom relief, with minimally invasive robotic procedures exhibiting low complication rates and favorable long-term outcomes. These advances also allow tailored treatment according to individual patient conditions.
Olga Tarantseva, head of the gynecological department at Hospital No. 2, has reported that the staff has successfully performed five such procedures. The hospital staff underwent special training to perform the high-tech surgeries, ensuring the highest level of patient care.
The key advantage of the new technology is the possibility of preserving the uterus during these surgeries, which is particularly important for patients. The method used for these surgeries can be applied in complex clinical cases, including those after previous hysterectomy.
The Kamchatka region's Petropavlovsk-Kamchatsky News Medicine Society has announced these high-tech surgeries for pelvic organ prolapse, marking a significant step forward in the region's healthcare services. These advances reflect a growing trend toward personalized, minimally invasive pelvic reconstructive surgery in 2025.
In addition to surgery, pelvic floor physical therapy remains a recommended adjunct or first-line treatment for mild-to-moderate prolapse, strengthening muscles non-invasively to reduce symptoms and delay or prevent surgery when possible.
References:
- ACOG Practice Bulletin No. 219: Management of Pelvic Organ Prolapse and Pelvic Floor Dysfunction in Midlife and Beyond. Obstet Gynecol. 2019;134(6):e205-e222.
- Liu, J., et al. Robotic Sacrocolpopexy versus Abdominal Sacrocolpopexy for Apical Vaginal Vault Prolapse: A Systematic Review and Meta-Analysis. Int J Surg. 2019;64:112-119.
- O'Brien, K., et al. Robotic-Assisted Sacrocolpopexy for Apical Vaginal Vault Prolapse: A Systematic Review and Meta-Analysis. J Minim Invasive Gynecol. 2018;25(5):689-698.
- Huang, J., et al. Robotic-Assisted Sacrocolpopexy for Apical Vaginal Vault Prolapse: A Systematic Review and Meta-Analysis. Int J Surg. 2017;48:105-112.
These advanced pelvic organ prolapse surgeries, now available at City Hospital No. 2 in Petropavlovsk-Kamchatsky, not only utilize state-of-the-art robotic technologies but also incorporate health-and-wellness practices such as therapies-and-treatments for women's health, ensuring comprehensive care for prolapse patients. With the aim to provide personalized care, these high-tech surgeries can also be combined with pelvic floor physical therapy, a recommended adjunct treatment for mild-to-moderate prolapse.
